December 5, 2017Open Access

HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

Key points are not available for this paper at this time.

Bill & Melinda Gates Foundation and World Health Organization.

Bookmark

View Full Paper

Cite This Study

Gupta et al. (Tue,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper